Exactly what kills a person with COVID-19?
How do those deaths differ from the deaths of people whose lungs fail rapidly because of other infections or injuries?
And what can hospital teams pressed into service on overtaxed COVID-19 wards do to try to keep patients from dying, despite strained circumstances?
All of these questions have sparked discussion - and even conspiracy theories - since the pandemic began. Now, two studies from Michigan Medicine may help answer them.
The bottom line: COVID-19 deaths are indeed different from other lung failure deaths. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar. It just needs to be fine-tuned to focus on the damage COVID-19 does to the lungs.
E-Mail
IMAGE: A novel study suggests that the behavior public officials are now mandating or recommending unequivocally to slow the spread of Covid-19 wearing a face covering should come with a caveat. If not. view more
Credit: Joshua Brown
A novel new study suggests that the behavior public officials are now mandating or recommending unequivocally to slow the spread of surging COVID-19 wearing a face covering should come with a caveat. If not accompanied by proper public education, the practice could lead to more infections.
The finding is part of an unique study, just published in
JMIR Public Health and Surveillance, that was conducted by a team of health economists and public health faculty at the University of Vermont s Larner College of Medicine in partnership with public health officials for the state of Vermont.
E-Mail
IMAGE: Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit:. view more
Credit: NIH
Focusing on the largest health care system in the Northeast, the study is among the first to document the pandemic s impact on cancer screening and diagnosis.
Screening and diagnoses rebounded in the months following the first surge of the pandemic.
The authors urge those who delayed screenings during the height of the pandemic to contact their health care provider to discuss the potential need to reschedule one.
E-Mail
IMAGE: A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial. view more
Credit: American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)
Leesburg, VA, January 14, 2021 According to ARRS
American Journal of Roentgenology (AJR), new suspicious findings occurred in 5.5% of breast MRI examinations performed to monitor response to neoadjuvant therapy; none of these new lesions were malignant. Our findings suggest that new lesions that arise in the setting of neoadjuvant therapy are highly unlikely to represent a new site of malignancy, particularly if the index malignancy shows treatment response, wrote Donna A. Eckstein and colleagues in the department of radiology and biomedical imaging at the University of California, San Francisco.
Which demographic and socioeconomic factors were associated with patient participation in telehealth during the COVID-19 pandemic surge was examined in this observational study.